Rosetta Genomics Ltd.
OTC: ROSGQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Douglas Sites
- Employees
- 86
- Headquarters
- Rehovot, Israel
- IPO year
- 2007
- Market cap
- $593.0
- Website
- https://www.rosettagenomics.com
Loading ROSGQ…
Loading profile data…Frequently asked questions about ROSGQ
What does Rosetta Genomics Ltd. (ROSGQ) do?
Rosetta Genomics Ltd. is a global entity specializing in genomic diagnostics. The company leverages its proprietary microRNA technologies to offer a range of diagnostic assays, including RosettaGX Cancer Origin, which helps pinpoint the primary source of metastatic cancer; mi-KIDNEY, designed for classifying kidney tumors from pathological speci...
Where does ROSGQ trade?
Rosetta Genomics Ltd. (ROSGQ) trades on the Other OTC.
What sector is ROSGQ in?
Rosetta Genomics Ltd. (ROSGQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Rosetta Genomics Ltd.?
Douglas Sites is the chief executive officer of Rosetta Genomics Ltd. (ROSGQ).
Where is Rosetta Genomics Ltd. headquartered?
Rosetta Genomics Ltd. is headquartered in Israel.
Does ROSGQ pay a dividend?
Rosetta Genomics Ltd. (ROSGQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ROSGQ go public?
Rosetta Genomics Ltd. (ROSGQ) completed its initial public offering in 2007.